Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
8.55
-0.29 (-3.28%)
May 9, 2025, 11:17 AM - Market open
Company Description
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States.
It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery.
The company was founded in 2014 and is headquartered in Waltham, Massachusetts.
Vicarious Surgical Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 123 |
| CEO | Adam Sachs |
Contact Details
Address: 78 Fourth Avenue Waltham, Massachusetts 02451 United States | |
| Phone | 617 868 1700 |
| Website | vicarioussurgical.com |
Stock Details
| Ticker Symbol | RBOT |
| Exchange | NYSE |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001812173 |
| CUSIP Number | 92561V109 |
| ISIN Number | US92561V1098 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Adam David Sachs | Co-Founder, Chief Executive Officer and Director |
| Sammy Khalifa | Co-founder, Chief Technology Officer and Director |
| Barry Stuart Greene F.A.C.S., M.D. | Co-founder and Chief Medical Officer |
| Kaitlyn Brosco | Director of Investor Relations |
| Erin Checka | Vice President of Legal and Secretary |
| Emma Plouffe | Vice President of Business Operations and People |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 1, 2025 | 144 | Filing |
| Apr 29, 2025 | ARS | Filing |
| Apr 29, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 29, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 11, 2025 | 8-K | Current Report |
| Mar 24, 2025 | 8-K | Current Report |
| Mar 21, 2025 | 144 | Filing |
| Mar 21, 2025 | 144 | Filing |
| Mar 21, 2025 | 144 | Filing |
| Mar 17, 2025 | 10-K | Annual Report |